Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-26
2011-04-26
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S051000, C544S105000, C544S175000, C544S350000, C546S176000, C546S245000, C546S314000, C548S362500, C548S503000, C548S530000, C549S407000
Reexamination Certificate
active
07932254
ABSTRACT:
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I,wherein the variables Q1and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
REFERENCES:
patent: 2006/0148801 (2006-07-01), Hsieh et al.
patent: 2007/0049615 (2007-03-01), Ibrahim et al.
patent: 0147922 (2001-07-01), None
patent: 03000688 (2003-01-01), None
patent: 03082868 (2003-10-01), None
patent: WO 2004/022562 (2004-03-01), None
patent: WO 2005/014599 (2005-02-01), None
patent: 2008033798 (2008-03-01), None
patent: 2008063888 (2008-05-01), None
patent: 2008079903 (2008-07-01), None
patent: WO 2009/077334 (2009-06-01), None
Hunter, T.Cell(1987) 50:823-829.
Rastetter, et al.Annu Rev Med(2004) 55:477-503.
Khan et al.Immunity(1995) 3:283-299.
Ellmeier, et al.J. Exp. Med.(2000) 192:1611-1623.
Rosen, et al.New Eng. J. Med.(1995) 333:431
Lindvall, et al.Immunol. Rev.(2005) 203:200-215.
Jansson and HolmdahlClin. Exp. Immunol.(1993) 94:459-465.
Pan, Z. et al.Chem. Med Chem.(2007) 2:58-61.
Iwaki, et al.J. Biol. Chem.(2005) 280:40261-40270.
Horwood, et al.J. Exp. Med.(2003) 197:1603-1611.
Islam and Smith,Immunol. Rev.(2000) 178:49-63.
Feldhahn, et al.J. Exp. Med.(2005) 201:1837-1852.
Vassilev, et al.J. Biol. Chem.(1998) 274, 1646-1656.
DuBois Daisy Joe
Hendricks Robert Than
Hermann Johannes Cornelius
Kondru Rama K.
Lou Yan
Johnston George W.
Kisko Jennifer L.
Roche Palo Alto
Tramaloni Dennis P.
Willis Douglas M
LandOfFree
Pyrrolopyrazine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolopyrazine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyrazine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2690016